For different GluCV categories, the initial inflammatory markers (WBC, NLR) were higher in individuals with higher GluCV, and the incidence of diabetes, septic shock, myocardial infarct, congestive heart failure, renal disease, and related treatments (RRT, MV, norepinephrine, and insulin infusion) was also elevated. This evidence concerns the gene INS and congestive heart failure.